Cargando…
269. Epidemiology and Outcomes of Invasive Aspergillosis (IA) Among Pediatric Immunocompromised Patients: A 12-Year, Single-Center Experience
BACKGROUND: IA remains a leading cause of morbidity and mortality in immunocompromised children, and our understanding regarding epidemiology and outcomes of IA are limited and based on adult studies. METHODS: We conducted a retrospective evaluation of cases of proven or probable IA according to the...
Autores principales: | Al Dhaheri, Fatima, Lee, Rose, Nakamura, Mari M, Marty, Francisco M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810524/ http://dx.doi.org/10.1093/ofid/ofz360.344 |
Ejemplares similares
-
Role of biomarkers in the diagnosis of invasive aspergillosis in immunocompromised patients
por: Badiee, Parisa, et al.
Publicado: (2022) -
358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)
por: Cheng, Matthew P, et al.
Publicado: (2018) -
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: van der Linden, Jan W.M., et al.
Publicado: (2016) -
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis
por: Alanio, Alexandre, et al.
Publicado: (2016) -
Aspergillosis myocarditis in the immunocompromised host
por: Bullis, Sean S., et al.
Publicado: (2019)